FiercePharma  Apr 25  Comment 
J&J, Novartis, Takeda eye for-sale stake in Brazilian drugmaker Hypermarcas chelfand Tue, 04/25/2017 - 15:38
FiercePharma  Apr 14  Comment 
FiercePharmaAsia—Mylan plant’s data issue, Takeda’s deal spree, China’s hardened trial data policy aliu Thu, 04/13/2017 - 21:36
GenEng News  Apr 11  Comment 
Takeda Pharmaceutical Company and NuBiyota are partnering to exploit the latter's  Microbial Ecosystem Therapeutic platform for d eveloping therapeutic oral microbial consortia products for gastroenterology indications. Under terms of the...
FierceBiotech  Apr 11  Comment 
NuBiyota pact continues Takeda’s GI, microbiome deal blitz nptaylor Tue, 04/11/2017 - 04:26
FiercePharma  Apr 7  Comment 
FiercePharmaAsia—Gilead’s manufacturing site in China, Takeda’s IBD deal and 180 Ariad job cuts aliu Fri, 04/07/2017 - 09:38
FiercePharma  Apr 6  Comment 
Intent on vaccine growth, Takeda clinches massive enrollment goal in phase 3 dengue study esagonowsky Thu, 04/06/2017 - 09:59
FiercePharma  Apr 5  Comment 
We have a winner: Takeda’s 'IBD Superheroes' takes DTC #FierceMadness trophy beth.bulik Wed, 04/05/2017 - 08:49
GenEng News  Apr 5  Comment 
Takeda is paying Finch Therapeutics $10 million upfront for exclusive, global rights to develop and commercialize the latter’s inflammatory bowel disease (IBD) candidate, FIN-524, together with rights to follow-on products for IBD indications. ...
GenEng News  Mar 30  Comment 
Takeda Pharmaceutical has absorbed only part of the nearly 300-employee workforce it inherited when it acquired Ariad Pharmaceuticals earlier this year, though exactly how many of the staffers it will ultimately hire has yet to be determined. ...
Financial Times  Mar 19  Comment 
Japanese pharma group only ‘at the beginning’ of transformation, says chief


No more s***. All posts of this qaultiy from now on

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki